Nasopharyngeal Carcinoma - 33 Studies Found
| Completed |
: Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2017-04-21 : Drug: Apatinib mesylate tablet Patients with locally recur |
| Completed |
: The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2015-05-17 :
|
| Not yet recruiting |
: Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients : Nasopharyngeal Carcinoma : 2016-07-23 :
|
| Not yet recruiting |
: Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2012-05-28 : Drug: endostatin Gemcitabine 1.0g/m2 d1,8 cisplatin 80mg/m2 endostatin 15mg/d 14days/cycle *4cycles |
| Not yet recruiting |
: Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients : Nasopharyngeal Carcinoma : 2014-01-21 :
|
| Completed |
: Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2017-03-06 : Diagnostic Test: Plasma EBV DNA Parameters analyzed will include (1) the change pattern of plasma EBV DN |
| Completed |
: Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2016-10-26 : Drug: Capecitabine Patients will receive capecitabine (650 mg/m2 bid, p.o.，d1-21，q3wks; co |
| Not yet recruiting |
: IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2017-02-15 :
|
| Completed |
: Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2015-05-23 :
|
| Not yet recruiting |
: Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma : Nasopharyngeal Carcinoma : 2016-09-13 :
|